We have previously shown with two independent cohorts that CRP levels >10 mg/L are linked to poor PFS and OS in ICI treated cancer patients and the likelihood of treatment benefit in these patients is very low (mPFS 2.0 months).26 The gene discussed is CRP; the disease is cancer.